Publications found:
36,576
Sort by:
North America Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product (University of Wisconsin Solution, Custodiol HTK, Perfadex, HypoThermosol, and Others), Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)
US$ 3,450.00
The North America organ preservation solution market was valued at US$ 1,23,239.05 thousand in 2023 and is expected to reach US$ 2,26,118.82 thousand by 2031; it is estimated to register a CAGR of 8.0...
April 2025
140 pages
South & Central America Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product (University of Wisconsin Solution, Custodiol HTK, Perfadex, HypoThermosol, and Others), Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)
US$ 3,450.00
The South & Central America organ preservation solution market was valued at US$ 16,602.01 thousand in 2023 and is expected to reach US$ 31,423.90 thousand by 2031; it is estimated to register a CAGR...
April 2025
115 pages
Asia Pacific Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The Asia Pacific biologics market was valued at US$ 1,01,590.5 million in 2023 and is expected to reach US$ 4,17,082.9 million by 2031; it is estimated to register a CAGR of 19.3% from 2023 to 2031. E...
April 2025
163 pages
Europe Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The Europe biologics market was valued at US$ 1,15,057.6 million in 2023 and is expected to reach US$ 4,15,468.4 million by 2031; it is estimated to register a CAGR of 17.4% from 2023 to 2031. Prefere...
April 2025
162 pages
Middle East & Africa Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The Middle East & Africa biologics market was valued at US$ 5,818.6 million in 2023 and is expected to reach US$ 17,939.1 million by 2031; it is estimated to register a CAGR of 15.1% from 2023 to 2031...
April 2025
153 pages
North America Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The North America biologics market was valued at US$ 230,256.1 million in 2023 and is expected to reach US$ 888,880.0 million by 2031; it is estimated to register a CAGR of 18.4% from 2023 to 2031. In...
April 2025
146 pages
South & Central America Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The South & Central America biologics market was valued at US$ 16,517.2 million in 2023 and is expected to reach US$ 54,534.7 million by 2031; it is estimated to register a CAGR of 16.1% from 2023 to...
April 2025
139 pages
Prader-Willi Syndrome Market - 2025-2033
US$ 3,400.00
Prader-Willi Syndrome Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Prader-Willi Syndrome Market emerges as a key focus in DataM Intelligence latest in-depth analy...
April 2025
47 pages
Cancer Diagnostic Market - 2025-2033
US$ 3,400.00
Cancer Diagnostic Marketis is growing with a CAGR of 8.70% during the forecast period 2026-2035. The Cancer Diagnostic Market emerges as a key focus in DataM Intelligence latest in-depth analysis, whe...
April 2025
43 pages
Global Influenza Market – Vaccines and Therapeutics
US$ 4,500.00
... a robust 8.5% CAGR between 2016 and 2022. Vaccines account for about 80% of the influenza market while therapeutics account for the remaining ... analyses and projects the Influenza therapeutics market at the global level while vaccines market is explored in and the regional markets including North America, Europe ...
April 2025
387 pages
Europe Pain Management Drugs Market - 2025-2033
US$ 2,499.00
Europe Pain Management Drugs Market reached US$ 17.13 billion in 2024 and is expected to reach US$ 33.77 billion by 2033, growing with a CAGR of 7.90% during the forecast period 2026-2033. The Europe...
April 2025
54 pages
Compounding Chemotherapy Market By Dose type (Chemotherapeutic, Non-chemotherapeutic), By Compounding Type (Pharmaceutical Ingredient Alteration, Currently Unavailable Pharmaceutical Manufacturing, Pharmaceutical Dosage Alteration), By Delivery method (Gravimetric automated Compounding Device, Volumetric Automated Compounding Device), By Sterility (Sterile, Non-sterile), By Technology (With Robotic arm, Without Robotic Arm): Global Opportunity Analysis and Industry Forecast, 2025-2034
US$ 2,655.00
The compounding chemotherapy market was valued at $5,267.03 million in 2024 and is estimated to reach $9,826.7 million by 2034, exhibiting a CAGR of 6.4% from 2025 to 2034.Compounding chemotherapy inv...
April 2025
364 pages
Dermatophytic Onychomycosis Treatment Market Forecasts to 2032 – Global Analysis By Product Type (Tablets, Nail Paints/Lacquers, Ointments & Creams, Laser Therapy Devices, Photodynamic Therapy (PDT) Solutions, and Other Product Types), Route of Administration, Treatment, Distribution Channel and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Dermatophytic Onychomycosis Treatment Market is accounted for $5.7 billion in 2025 and is expected to reach $10.8 billion by 2032 growing at a CAGR of 9.5% dur...
April 2025
150 pages
Vaccine Market Report by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), and Region 2025-2033
US$ 2,999.00
The global vaccine market size reached USD 59.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 136.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.12% during 202...
April 2025
144 pages
Locally Advanced Pancreatic Cancer Market - 2025-2033
US$ 3,400.00
Locally Advanced Pancreatic Cancer Market reached US$ 1.31 billion in 2024 and is expected to reach US$ 2.38 billion by 2033, growing with a CAGR of 7.00% during the forecast period 2026-2033. The Loc...
April 2025
60 pages
Neuroleptic Drugs Market - 2024-2031
US$ 3,400.00
Neuroleptic Drugs Marketis is growing with a CAGR of 5.60% during the forecast period 2026-2035. The Neuroleptic Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, whe...
March 2025
43 pages
Renin-Inhibitors Market - 2024-2031
US$ 3,400.00
Renin-Inhibitors Marketis is growing with a CAGR of 6.70% during the forecast period 2026-2035. The Renin-Inhibitors Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...
March 2025
42 pages
Gaucher Disease Pipeline Insights 2025 2026
US$ 2,999.00
The Gaucher Disease Pipeline Insights 2025 was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includi...
March 2025
210 pages
